Now that we are in the “dog days” of summer, it’s time again to consider which books to pack (or load onto your e-reader) for your well-deserved getaway to the beach and beyond. With so many interesting titles published every year, it’s never easy to make recommendations. But I thought it might be fun to ask a few distinguished researchers to share a few of their favorite reads—both about science and other things in the world at large. Some might be classics; some might have just been published. It’s up to the guests to decide.
During the month of August, the NIH Director’s Blog will run a series of guest posts in which some of biomedical science’s most creative minds discuss one or two of the books they’ve been reading. I’m sure what they share will be informative, provocative, and possibly even provide you with a few more possibilities for your late summer reading list. So, please check out the blog next Tuesday for the first installment in our scientists’ summer reading series, which happens to be penned by an avid reader who also holds a Nobel Prize in Physiology or Medicine. Can anyone guess who it is?
Thanks to your swift and overwhelming response, the NIH Director’s Blog survey is now closed. I’d like to thank everyone who took the time to respond. Your feedback is greatly appreciated and will be used to help shape the blog as we move forward.
From my “house” at NIH to yours, I’d like to wish each of you and your loved ones a wonderful holiday season and a happy, healthful New Year. Throughout the past year, I hope that you’ve enjoyed the entries in this blog, sharing just a few of the many breakthroughs in biomedical research and introducing you to some of the young scientists who fill me with such hope for the future. As we prepare to turn the NIH Director’s Blog calendar to 2016, I look forward to bringing you even more exciting discoveries that show the power of science to build a healthier tomorrow.
But I need your help! In this season of giving, I’d like to ask each of you for a little something: your thoughts on how to make what I think is a good blog even better. So, please click on the “gift” below to take part in a brief, anonymous survey that should take no more than a couple of minutes. Thanks so much for your time!
Caption: Dr. Nancy Sullivan of NIH’s National Institute of Allergy and Infectious Diseases (NIAID) discussing Ebola research with President Barack Obama as NIAID Director Dr. Anthony Fauci and HHS Secretary Sylvia Burwell look on.
Today, we had the great honor of welcoming President Barack Obama to the campus of the National Institutes of Health (NIH) in Bethesda, MD—to see first-hand the progress that biomedical research is making against Ebola virus disease. The President toured the NIH Vaccine Research Center, and met with scientists who are working hard to develop ways to combat this deadly virus that continues to devastate West Africa. And, in a speech before a packed auditorium at the NIH Clinical Center, the President praised the contributions of NIH staff. He also emphasized the need for emergency Congressional authorization of resources to ensure that our nation’s research and public health efforts against Ebola will lead as quickly as possible to an end to this devastating outbreak.
The President heard about many encouraging advances against Ebola during his visit here, and I’d like to share a couple with you now. I think these examples—one about a vaccine and one about a treatment—speak to the extraordinary ways in which scientists from different fields, disciplines, and organizations are pulling together to tackle this urgent disease threat.
The brain shrinks as we age—it’s normal. But in Alzheimer’s disease, neurons die-off in the billions, causing the brain to shrink more rapidly. Initially the disease wipes out neurons in brain structures that create and store memories. The disease then destroys regions responsible for language and behavior. As the rest of the brain breaks down, Alzheimer’s patients lose touch with the world and the people around them.
The NIH is testing therapies to treat, delay, and ultimately prevent Alzheimer’s disease.
For more information: